# Edmond de Rothschild Venture Capital: portfolio, investments and team > Edmond de Rothschild Venture Capital is a growth equity. 54 investments on record, latest Jun 2015. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/edmond-de-rothschild-venture-capital (Millionrounds; every figure on the page links to its filing or article) [Investor](https://millionrounds.com/investors) # Edmond de Rothschild Venture Capital Last cheque observed Jun 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet Growth equity Series B Series A Series C Cheques on record **0%** of best year **0** **cheques in 12 months**, 54 on record Since the last cheque **4141** days **00** hrs **00** min **00** sec Median round **$20M** Rounds led **0 of 54** Sole investor **4 rounds** Exits **7 from the portfolio** Mostly in **France, 36%** Pitch Edmond de Rothschild Venture Capital ## Edmond de Rothschild Venture Capital highlights - 01 54 rounds on record - 02 Mostly Series B and Series A: 54% of its rounds - 03 Sole investor in 4 rounds, median $3.0M - 04 7 exits from the portfolio ## What they do - **Type:** Growth equity (from a list, unverified) - **Cheque size:** Not stated - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **54 appearances** - **2015** 3 rounds - **Jun** **[Autonomic Technologies](https://millionrounds.com/company/autonomic-technologies)** Series D · US **$43M** With 7 others - **May** **[Autonomic Technologies](https://millionrounds.com/company/autonomic-technologies)** Series D · US **$38M** With 4 others - **Jan** **[Genkyotex](https://millionrounds.com/company/genkyotex)** Series D · CH **$21M** With 5 others - **2014** 5 rounds - **Nov** **[Finsecur](https://millionrounds.com/company/finsecur)** Venture · PT **$31M** With 1 other - **Sept** **[Poxel](https://millionrounds.com/company/poxel)** Series B · FR **$14M** With 1 other - **May** **[Chase Pharmaceuticals](https://millionrounds.com/company/chase-pharmaceuticals)** Series B · US **$21M** With 2 others - **Mar** **[Axonics Modulation Technologies](https://millionrounds.com/company/axonics-modulation-technologies)** Series A · US **$33M** With 2 others - **Mar** **[Inotrem](https://millionrounds.com/company/inotrem)** Series A · FR **$23M** With 1 other - **2013** 7 rounds - **Dec** **[Covagen](https://millionrounds.com/company/covagen)** Series B · CH · pehub.com **$47M** With 7 others - **Jul** **[JenaValve Technology](https://millionrounds.com/company/jenavalve-technology)** Series C · DE · finsmes.com **$63M** With 7 others - **Jul** **[OncoEthix](https://millionrounds.com/company/oncoethix)** Series B · CH · finsmes.com **$19M** With 3 others - **Jun** **[Complix](https://millionrounds.com/company/complix)** Series B · BE · prnewswire.com **$15M** With 7 others - **Apr** **[Genticel](https://millionrounds.com/company/genticel)** Series D · FR · finsmes.com **$24M** With 4 others - **Apr** **[Allecra Therapeutics](https://millionrounds.com/company/allecra-therapeutics)** Series A · FR · finance.yahoo.com **$20M** With 2 others - **Jan** **[Turbocoating](https://millionrounds.com/company/turbocoating)** Venture · IT · finsmes.com **$26M** With 2 others - **2012** 4 rounds - **Dec** **[Regado Biosciences](https://millionrounds.com/company/regado-biosciences)** Series E · US · regadobio.investorroom.com **$51M** With 8 others - **Nov** **[Endosense](https://millionrounds.com/company/endosense)** Series C · CH · finsmes.com **$40M** With 7 others - **Jul** **[Genkyotex](https://millionrounds.com/company/genkyotex)** Series C · CH · finance.yahoo.com **$26M** With 3 others - **Jan** **[Probiodrug](https://millionrounds.com/company/probiodrug)** Venture · DE · finsmes.com **$19M** With 5 others - **2011** 4 rounds - **Aug** **[Vessix Vascular](https://millionrounds.com/company/vessix-vascular)** Series B · US · finsmes.com **$23M** With 3 others - **Jun** **[Sapiens](https://millionrounds.com/company/sapiens)** Series A · DE · cisionwire.com **$19M** With 2 others - **May** **[Genkyotex](https://millionrounds.com/company/genkyotex)** Series C · CH · reuters.com **$20M** With 4 others - **Feb** **[CellNovo](https://millionrounds.com/company/cellnovo)** Series B · GB · cellnovo.com **$48M** With 8 others - **2010** 9 rounds - **Nov** **[SuperSonic Imagine](https://millionrounds.com/company/supersonic-imagine)** Series C · FR · businesswire.com **$45M** With 7 others - **Nov** **[Covagen](https://millionrounds.com/company/covagen)** Series A · CH · covagen.com **$6.3M** With 4 others - **Sept** **[Garden Price](https://millionrounds.com/company/garden-price)** Venture · FR · finsmes.com **$2.7M** Sole investor - **Aug** **[Poxel](https://millionrounds.com/company/poxel)** Series A · FR · onbiovc.com **$20M** With 3 others - **Jul** **[Implanet](https://millionrounds.com/company/implanet)** Series D · FR · onbiovc.com **$10M** With 2 others - **Apr** **[Implanet](https://millionrounds.com/company/implanet)** Series C · FR **$11M** With 4 others - **Apr** **[Genticel](https://millionrounds.com/company/genticel)** Series C · FR · onbiovc.com **$18M** With 3 others - **Feb** **[PDC Biotech](https://millionrounds.com/company/pdc-biotech)** Series A · AT · onbiovc.com **$5.5M** With 1 other - **Jan** **[Smile](https://millionrounds.com/company/smile)** Venture · FR · finsmes.com **$3.6M** Sole investor - **2009** 6 rounds - **Dec** **[Regado Biosciences](https://millionrounds.com/company/regado-biosciences)** Series D · US · regadobio.com **$40M** With 5 others - **Nov** **[Probiodrug](https://millionrounds.com/company/probiodrug)** Series B · DE · probiodrug.de **$54M** With 7 others - **Oct** **[Endosense](https://millionrounds.com/company/endosense)** Series B · CH · onbiovc.com **$36M** With 6 others - **Sept** **[Santen Pharmaceutical](https://millionrounds.com/company/santen-pharmaceutical)** Series D **$22M** With 6 others - **Jun** **[Implanet](https://millionrounds.com/company/implanet)** Series B · FR **$13M** With 3 others - **Mar** **[GlycoVaxyn](https://millionrounds.com/company/glycovaxyn)** Series B · CH · bio-medicine.org **$21M** With 2 others - **2008** 2 rounds - **Oct** **[SuperSonic Imagine](https://millionrounds.com/company/supersonic-imagine)** Series B · FR **$26M** With 4 others - **Apr** **[AJ Tech](https://millionrounds.com/company/aj-tech)** Series A · FR · fusacq.com **$1.3M** Sole investor An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## Exits from the portfolio Companies it backed that were later bought or listed **7 in all** **[GlycoVaxyn](https://millionrounds.com/company/glycovaxyn)** Bought by [GSK Venture Fund](https://millionrounds.com/fund/gsk-venture-fund) **$190M** Feb 2015 **[OncoEthix](https://millionrounds.com/company/oncoethix)** Bought by Merck & Co. **Undisclosed** Dec 2014 **[Sapiens](https://millionrounds.com/company/sapiens)** Bought by [Medtronic](https://millionrounds.com/fund/medtronic) **$200M** Aug 2014 **[Covagen](https://millionrounds.com/company/covagen)** Bought by Cilag **Undisclosed** Aug 2014 **[Endosense](https://millionrounds.com/company/endosense)** Bought by [St. Jude Medical](https://millionrounds.com/fund/st-jude-medical) **$170M** Aug 2013 **[Vessix Vascular](https://millionrounds.com/company/vessix-vascular)** Bought by [Boston Scientific](https://millionrounds.com/fund/boston-scientific) **$300M** Nov 2012 **[MeeVee](https://millionrounds.com/company/meevee)** Bought by LiveUniverse **Undisclosed** May 2008 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Series B Series A Series C Median round joined **$20M** the round, not its cheque Alone, median **$3.0M** Led 0 of 54 rounds **0%** - **Sole investor:** 4 rounds - **Last cheque:** Jun 2015 - **Exits:** 7 from the portfolio Rounds by stage said on their site - Series B *18* - Series A *11* - Series C *10* - Series D *8* - Venture *6* - Series E *1* Cheques by year Led Joined 1994 2015 Often in the room with - [Auriga Partners](https://millionrounds.com/fund/auriga-partners) 12 - [Omnes](https://millionrounds.com/fund/omnes-capital) 7 - [Bpifrance](https://millionrounds.com/fund/bpifrance) 6 - [Wellington Partners](https://millionrounds.com/fund/wellington-partners) 6 - [Gimv](https://millionrounds.com/fund/gimv) 5 - [Idinvest Partners](https://millionrounds.com/fund/idinvest-partners) 5 **Pitching Edmond de Rothschild Venture Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Edmond de Rothschild Venture Capital. A count of rooms they were both in, not a relationship either has claimed. [**Auriga Partners** VC firm **12** rounds together](https://millionrounds.com/fund/auriga-partners)[**Omnes** VC firm **7** rounds together](https://millionrounds.com/fund/omnes-capital)[**Bpifrance** Government **6** rounds together](https://millionrounds.com/fund/bpifrance)[**Wellington Partners** VC firm **6** rounds together](https://millionrounds.com/fund/wellington-partners)[**Gimv** Private equity **5** rounds together](https://millionrounds.com/fund/gimv)[**Idinvest Partners** Private equity **5** rounds together](https://millionrounds.com/fund/idinvest-partners)[**NeoMed** Growth equity **5** rounds together](https://millionrounds.com/fund/neomed)[**MP Healthcare Venture Management** Corporate VC **4** rounds together](https://millionrounds.com/fund/mp-healthcare-venture-management)[**Novartis Venture Fund** Corporate VC **4** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**Sofinnova Partners** VC firm **4** rounds together](https://millionrounds.com/fund/sofinnova-partners)[**VI Partners** VC firm **4** rounds together](https://millionrounds.com/fund/vi-partners)[**123Venture** VC firm **3** rounds together](https://millionrounds.com/fund/123venture) ## Quick answers about Edmond de Rothschild Venture Capital ### What does Edmond de Rothschild Venture Capital invest in? Edmond de Rothschild Venture Capital invests most often at Series B and Series A (54% of the rounds on record). ### How active is Edmond de Rothschild Venture Capital? 54 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2015. ### How big are Edmond de Rothschild Venture Capital's cheques? The median round it joins is $20M. ### Does Edmond de Rothschild Venture Capital lead rounds? Rarely, if at all: none of its 54 investments on record names it as the lead. ### Where does Edmond de Rothschild Venture Capital invest? Most of the companies it backs are in France (36%), Switzerland (23%) and the United States (18%). ### Is Edmond de Rothschild Venture Capital investing now? No investments in the last 12 months; the latest was in Jun 2015. ### Who does Edmond de Rothschild Venture Capital invest alongside? Most often Auriga Partners (12 rounds together), Omnes (7 rounds together) and Bpifrance (6 rounds together). ### What kind of investor is Edmond de Rothschild Venture Capital? Edmond de Rothschild Venture Capital is a growth equity firm. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=edmond-de-rothschild-venture-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=edmond-de-rothschild-venture-capital)